Literature DB >> 10779255

Recognition of common childhood malignancies.

G Young1, J A Toretsky, A B Campbell, A E Eskenazi.   

Abstract

Although cancer has an annual incidence of only about 150 new cases per 1 million U.S. children, it is the second leading cause of childhood deaths. Early detection and prompt therapy have the potential to reduce mortality. Leukemias, lymphomas and central nervous system tumors account for more than one half of new cancer cases in children. Early in the disease, leukemia may cause nonspecific symptoms similar to those of a viral infection. Leukemia should be suspected if persistent vague symptoms are accompanied by evidence of abnormal bleeding, bone pain, lymphadenopathy or hepatosplenomegaly. The presenting symptoms of a brain tumor may include elevated intracranial pressure, nerve abnormalities and seizures. A spinal tumor often presents with signs and symptoms of spinal cord compression. In children, lymphoma may present as one or more painless masses, often in the neck, accompanied by signs and symptoms resulting from local compression, as well as signs and symptoms of systemic disturbances, such as fever and weight loss. A neuroblastoma may arise from sympathetic nervous tissue anywhere in the body, but this tumor most often develops in the abdomen. The presentation depends on the local effects of the solid tumor and any metastases. An abdominal mass in a child may also be due to Wilms' tumor. This neoplasm may present with renal signs and symptoms, such as hypertension, hematuria and abdominal pain. A tumor of the musculoskeletal system is often first detected when trauma appears to cause pain and dysfunction out of proportion to the injury. Primary care physicians should be alert for possible presenting signs and symptoms of childhood malignancy, particularly in patients with Down syndrome or other congenital and familial conditions associated with an increased risk of cancer.

Entities:  

Mesh:

Year:  2000        PMID: 10779255

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  9 in total

1.  [Imaging of abdominal tumors in childhood and adolescence : Part I: Background, hepatic, splenic and pancreatic tumors].

Authors:  D M Renz; H-J Mentzel
Journal:  Radiologe       Date:  2018-06       Impact factor: 0.635

Review 2.  Gastrointestinal and liver infections in children undergoing antineoplastic chemotherapy in the years 2000.

Authors:  Elio Castagnola; Eliana Ruberto; Alfredo Guarino
Journal:  World J Gastroenterol       Date:  2016-07-07       Impact factor: 5.742

3.  Resveratrol reverses P-glycoprotein-mediated multidrug resistance of U2OS/ADR cells by suppressing the activation of the NF-κB and p38 MAPK signaling pathways.

Authors:  Rui Zhang; Ming Lu; Zhen Zhang; Xiliang Tian; Shouyu Wang; Decheng Lv
Journal:  Oncol Lett       Date:  2016-09-14       Impact factor: 2.967

4.  Clinical characteristics of childhood cancer in emergency room in a tertiary hospital in Pakistan.

Authors:  Amna Jawaid; Khubaib Arif; Nick Brown; Zehra Fadoo
Journal:  World J Emerg Med       Date:  2016

5.  Clinicopathological Profile of Childhood Primary Abdominal Tumours in Kashmir.

Authors:  Parwez Sajad Khan; Zahida Akhter; Showkat Majeed; Mohd Yousuf Wani; Humera Hayat
Journal:  Indian J Surg       Date:  2013-01-31       Impact factor: 0.656

Review 6.  Antibody therapies for lymphoma in children.

Authors:  Verena de Zwart; Samantha C Gouw; Friederike A G Meyer-Wentrup
Journal:  Cochrane Database Syst Rev       Date:  2016-01-19

7.  Serum adiponectin and resistin levels in de novo and relapsed acute lymphoblastic leukemia children patients.

Authors:  Hatim A El-Baz; Tamer E Mosa; Elham M Elabd; Amal Ramadan; Ahmed S Elharoun; Elsayed A Elmorsy; Manal I Fouda
Journal:  Iran J Public Health       Date:  2013-05-01       Impact factor: 1.429

8.  Short-Term PTEN Inhibition Improves In Vitro Activation of Primordial Follicles, Preserves Follicular Viability, and Restores AMH Levels in Cryopreserved Ovarian Tissue From Cancer Patients.

Authors:  Edurne Novella-Maestre; Sonia Herraiz; Beatriz Rodríguez-Iglesias; César Díaz-García; Antonio Pellicer
Journal:  PLoS One       Date:  2015-05-29       Impact factor: 3.240

Review 9.  Current Challenges in Volatile Organic Compounds Analysis as Potential Biomarkers of Cancer.

Authors:  Kamila Schmidt; Ian Podmore
Journal:  J Biomark       Date:  2015-03-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.